Search All News
If untreated, glaucoma can lead to irreversible vision loss. A Columbia screening program is finding more people with the disease than expected.
An initiative led by a Columbia ophthalmologist seeks to improve the treatment of eye trauma, a serious but neglected condition second only to cataracts as the most common cause of visual impairment.
Steven E. Rosenberg, MD, an expert in strabismus and pediatric ophthalmology, joins Columbia.
- April 27, 2021
Residents of some NYC public housing developments can get free vision screening and eye exams in their building as part of a new study led by Columbia University’s Department of Ophthalmology.
- March 22, 2021
Treatments for a rare retinal disease may be on the horizon after a new study identifies gene variants that cause a metabolic deficiency in the eye.
- March 9, 2021
A clinical trial to test a gene therapy for some patients with dry age-related macular degeneration—a leading cause of blindness in the United States—is underway at Columbia and NewYork-Presbyterian.
- December 18, 2020
Simon John, PhD, professor of ophthalmology, has been awarded the Sanford and Susan Greenberg Visionary Prize for his research on glaucoma.
- August 3, 2020
New genetic and patient analyses suggest severe COVID is linked to overactive complement, one of the immune system’s oldest branches, and excess blood clotting.
- June 29, 2020
New eye drops could prevent vision loss after retinal vein occlusion, a major cause of blindness for millions of adults, a study by Columbia University researchers has found.
- November 8, 2019
Columbia researchers have found hundreds of genes linked to nearsightedness, and now they’re using the data to screen for new drugs that can safeguard sharp vision.
- January 18, 2019
Vagelos student Emery Jamerson’19 received the 2018 Dr. David K. McDonogh Scholarship in Ophthalmology/ENT, named for the first black Columbia-trained doctor in New York.
- November 15, 2018
The most common tests for glaucoma can underestimate the severity of the condition because they do not detect the presence of central vision loss, ophthalmologists at Columbia have found.